• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • J.-F. Dhainaut, Sau Chi Betty Yan, +5 authors Marcel Levi
  • Medicine
  • Journal of thrombosis and haemostasis : JTH
  • 2004 (First Published: 1 November 2004)
  • Disseminated intravascular coagulation (DIC) is a serious condition associated with sepsis. Clinical management of DIC is hampered by lack of clear diagnostic criteria. The International Society onContinue Reading
  • Gary T. Kinasewitz, Sau Chi Betty Yan, +7 authors Jean-François Dhainaut
  • Medicine
  • Critical care
  • 2004 (First Published: 10 February 2004)
  • IntroductionPROWESS (Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis) was a phase III, randomized, double blind, placebo controlled, multicenter trial conducted inContinue Reading
  • Sau Chi Betty Yan, Victoria L. Peek, +19 authors Richard A. Walgren
  • Medicine
  • Investigational New Drugs
  • 2012 (First Published: 1 August 2013)
  • SummaryThe HGF/MET signaling pathway regulates a wide variety of normal cellular functions that can be subverted to support neoplasia, including cell proliferation, survival, apoptosis, scatteringContinue Reading
  • Christophe Adrie, Mehran Monchi, +6 authors Jean François Dhainaut
  • Medicine
  • Journal of the American College of Cardiology
  • 2005 (First Published: 1 July 2005)
  • OBJECTIVES We investigated coagulation abnormalities in out-of-hospital cardiac arrest (OHCA) patients, with special attention to the protein C anticoagulant pathway. BACKGROUND SuccessfullyContinue Reading
  • Jean-François Dhainaut, Sau Chi Betty Yan, +8 authors Gary T. Kinasewitz
  • Medicine
  • Thrombosis and haemostasis
  • 2003 (First Published: 16 August 2003)
  • Drotrecogin alfa (activated) improved survival in patients with severe sepsis in PROWESS, a double-blind, study of 1690 adult patients randomized to drotrecogin alfa (activated) at 24 microg/kg/hContinue Reading